BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25268843)

  • 1. Baicalein inhibits agonist- and tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation.
    Kim SD; Lee YJ; Baik JS; Han JY; Lee CG; Heo K; Park YS; Kim JS; Ji HD; Park SI; Rhee MH; Yang K
    Biochem Pharmacol; 2014 Nov; 92(2):251-65. PubMed ID: 25268843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin eugenol ester inhibits agonist-induced platelet aggregation in vitro by regulating PI3K/Akt, MAPK and Sirt 1/CD40L pathways.
    Shen DS; Yang YJ; Kong XJ; Ma N; Liu XW; Li SH; Jiao ZH; Qin Z; Huang MZ; Li JY
    Eur J Pharmacol; 2019 Jun; 852():1-13. PubMed ID: 30797789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
    Endale M; Lee WM; Kamruzzaman SM; Kim SD; Park JY; Park MH; Park TY; Park HJ; Cho JY; Rhee MH
    Br J Pharmacol; 2012 Sep; 167(1):109-27. PubMed ID: 22471932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.
    Kamruzzaman SM; Yayeh T; Ji HD; Park JY; Kwon YS; Lee IK; Kim S; Oh SH; Kim SD; Roh SS; Yun BS; Rhee MH
    Vascul Pharmacol; 2013; 59(3-4):83-9. PubMed ID: 23872194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
    Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
    J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
    J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel compound MP407 inhibits platelet aggregation through cyclic AMP-dependent processes.
    Lin CS; Chen TH; Lin IH; Lee AR; Chou TC
    Eur J Pharmacol; 2017 Nov; 815():324-331. PubMed ID: 28939294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
    Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
    EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N1-(Quinolin-2-ylmethyl) butane-1, 4-diamine, a polyamine analog: inhibition of platelet aggregation mediated by an elevated VASP, and decreased MAPK phosphorylation.
    Gao Y; Ji BS
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):476-85. PubMed ID: 24509331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rutaecarpine, an Alkaloid from
    Huang CJ; Huang WC; Lin WT; Shu LH; Sheu JR; Tran OT; Hsia CW; Jayakumar T; Bhavan PS; Hsieh CY; Chang CC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
    Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
    Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
    Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
    Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peroxisome proliferator-activated receptor γ in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases.
    Du H; Hu H; Zheng H; Hao J; Yang J; Cui W
    Thromb Res; 2014 Jul; 134(1):111-20. PubMed ID: 24856644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3K/Akt pathway.
    Yu X; Yang Y; Li Y; Cao Y; Tang L; Chen F; Xia J
    Int J Biochem Cell Biol; 2018 Jan; 94():107-118. PubMed ID: 29175387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.
    Chao JI; Su WC; Liu HF
    Mol Cancer Ther; 2007 Nov; 6(11):3039-48. PubMed ID: 18025287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.